AnaCardio - Crunchbase Company Profile & Funding

Q: Where is AnaCardio's headquarters?

AnaCardio is located in Solna, Stockholms Lan, Sweden.

Q: Who invested in AnaCardio?

AnaCardio has 10 investors including Fredrik Ljungström And Flerie Invest.

Q: When was the last funding round for AnaCardio?

AnaCardio closed its last funding round on obfuscated from a Series A round.

Q: How much funding has AnaCardio raised to date?

AnaCardio has raised obfuscated.

Overview

AnaCardio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About AnaCardio

CB Rank

34409

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Founded

obfuscation

Private

Series A

Solna, Stockholms Lan, Sweden

11-50

anacardio.com

Biopharma

Biotechnology

Medical

Funding Rounds

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Debt Financing

OBF

obfuscation

Key People

Patrik Stromberg: CEO
Past Role: Sobi, Vice President, External Innovation, Search Evaluation
Philipp Mathieu: Chief Financial Officer
Past Role: Immunovia, CEO & President

Details

Legal Name

AnaCardio AB

Operating Status

Active

Company Type

For Profit

About the Company

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Predictions & Insights

Growth Insight

See this Growth Insight

AnaCardio is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

AC01

An oral ghrelin peptidomimetic small-molecule designed to increase cardiac contractility safely in heart failure patients.

Research & Development

AnaCardio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - AnaCardio	7	obfuscated obfuscation	Novo Holdings, Pureos Bioventures, Sound Bioventures	Series A
obfuscated obfuscation	Series A - AnaCardio	7	obfuscated obfuscation	Novo Holdings, Pureos Bioventures, Sound Bioventures	Series A
obfuscated obfuscation	Series A - AnaCardio	7	obfuscated obfuscation	Novo Holdings, Pureos Bioventures, Sound Bioventures	Series A
obfuscated obfuscation	Series A - AnaCardio	7	obfuscated obfuscation	Novo Holdings, Pureos Bioventures, Sound Bioventures	Series A
obfuscated obfuscation	Series A - AnaCardio	7	obfuscated obfuscation	Novo Holdings, Pureos Bioventures, Sound Bioventures	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - AnaCardio	7	obfuscated obfuscation	Novo Holdings, Pureos Bioventures, Sound Bioventures	Series A
obfuscated obfuscation	Series A - AnaCardio	7	obfuscated obfuscation	Novo Holdings, Pureos Bioventures, Sound Bioventures	Series A
obfuscated obfuscation	Series A - AnaCardio	7	obfuscated obfuscation	Novo Holdings, Pureos Bioventures, Sound Bioventures	Series A
obfuscated obfuscation	Series A - AnaCardio	7	obfuscated obfuscation	Novo Holdings, Pureos Bioventures, Sound Bioventures	Series A
obfuscated obfuscation	Series A - AnaCardio	7	obfuscated obfuscation	Novo Holdings, Pureos Bioventures, Sound Bioventures	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Fredrik Ljungström	—	Series A - AnaCardio	—
Fredrik Ljungström	—	Series A - AnaCardio	—
Fredrik Ljungström	—	Series A - AnaCardio	—
Fredrik Ljungström	—	Series A - AnaCardio	—
Fredrik Ljungström	—	Series A - AnaCardio	—